摘要
自2019年12月新型冠状病毒严重急性呼吸综合征冠状病毒2型(severe acute respiratory syndrome coronavirus 2,SARS-CoV-2)所致新型冠状病毒肺炎(coronavirus disease 2019,COVID-19)爆发以来,张志明教授被甘肃省卫生健康委员会任命为COVID-19中医防治组组长,全程跟进甘肃省COVID-19的治疗工作,并根据甘肃省COVID-19的形势和发病特点,在疫情的防控过程中极力推荐和支持中医药的使用,在保证甘肃省所有COVID-19患者"一人一方"的中医治疗策略前提下,中西医并重,各取所长,取得了明显的临床疗效。
Since the outbreak of COVID-19 caused by SARS-CoV-2 in December, 2019, professor Zhang Zhiming has been appointed the head of TCM prevention and treatment team for COVID-19 by Health Commission of Gansu Province, he has been following up the treatment for COVID-19 in Gansu province comprehensively. In light of the current situation and onset characteristics of COVID-19 in Gansu province, he strongly recommended and supported the use of TCM in the process of epidemic prevention and control, on the premise of ensuring TCM therapeutic strategy of "one person, one prescription", he combined TCM with Western medicine, employed both advantages and obtained notable clinical effects.
作者
宋忠阳
雍文兴
张利英
王功臣
王庆胜
刘永琦
张志明
SONG Zhongyang;YONG Wenxing;ZHANG Liying;WANG Gongchen;WANG Qingsheng;LIU Yongqi;ZHANG Zhiming(Clinical College of TCM,Gansu University of Chinese medicine,Lanzhou 730000,China;Emergency Department,Affiliated Hospital of Gansu University of Chinese medicine;College of Integrated Chinese and Western medicine,Gansu University of Chinese Medicine;Oncology Department,Affiliated Hospital of Gansu University of Chinese Medicine;Department of Respiratory Medicine,Affiliated Hospital of Gansu University of Chinese Medicine)
出处
《西部中医药》
2020年第3期1-5,共5页
Western Journal of Traditional Chinese Medicine
基金
甘肃省新型冠状病毒肺炎(NCP)科技重大专项。
关键词
新型冠状病毒肺炎
中医
辨证论治
主力军
张志明
COVID-19
TCM
syndrome differentiation and treatment
main force
Zhang Zhiming
作者简介
宋忠阳(1991—),男,在读博士研究生。研究方向:急危重症的中医药防治;通讯作者:张志明(1964—),男,主任医师,教授,研究方向:急危重症的中医药防治。
